Huggins Erin, Ong Ricardo, Rockman-Greenberg Cheryl, Flueckinger Lauren Bailey, Dahir Kathryn M, Kishnani Priya S
Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.
Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Mol Genet Metab Rep. 2020 Oct 21;25:100661. doi: 10.1016/j.ymgmr.2020.100661. eCollection 2020 Dec.
Hypophosphatasia (HPP) is an inherited metabolic condition caused by pathogenic mutations in the gene. This leads to deficiency of tissue non-specific alkaline phosphatase (TNSALP), resulting in decreased mineralization of the bones and/or teeth and multi-systemic complications. Inheritance may be autosomal dominant or recessive, and the phenotypic spectrum, including age of onset, varies widely. We present four families demonstrating both modes of inheritance of HPP and phenotypic variability and discuss the resultant challenges in disease management, genetic counseling, and risk assessment. Failure to consider different modes of inheritance in a family with HPP may lead to an inaccurate risk assessment upon which medical and reproductive decisions may be made. We highlight the essential role of high-quality genetic counseling and meaningful biochemical and molecular testing strategies in the evaluation and management of families with HPP.
低磷性骨软化症(HPP)是一种由该基因的致病性突变引起的遗传性代谢疾病。这会导致组织非特异性碱性磷酸酶(TNSALP)缺乏,从而导致骨骼和/或牙齿矿化减少以及多系统并发症。遗传方式可能为常染色体显性或隐性,其表型谱,包括发病年龄,差异很大。我们展示了四个体现HPP两种遗传模式和表型变异性的家族,并讨论了疾病管理、遗传咨询和风险评估中由此产生的挑战。在一个患有HPP的家族中,未能考虑不同的遗传模式可能会导致不准确的风险评估,进而可能据此做出医疗和生殖决策。我们强调了高质量遗传咨询以及有意义的生化和分子检测策略在HPP家族评估和管理中的重要作用。